BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25461287)

  • 1. S-nitrosocaptopril nanoparticles as nitric oxide-liberating and transnitrosylating anti-infective technology.
    Mordorski B; Pelgrift R; Adler B; Krausz A; da Costa Neto AB; Liang H; Gunther L; Clendaniel A; Harper S; Friedman JM; Nosanchuk JD; Nacharaju P; Friedman AJ
    Nanomedicine; 2015 Feb; 11(2):283-91. PubMed ID: 25461287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione.
    Friedman AJ; Blecher K; Schairer D; Tuckman-Vernon C; Nacharaju P; Sanchez D; Gialanella P; Martinez LR; Friedman JM; Nosanchuk JD
    Nitric Oxide; 2011 Nov; 25(4):381-6. PubMed ID: 21946032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response.
    Nacharaju P; Tuckman-Vernon C; Maier KE; Chouake J; Friedman A; Cabrales P; Friedman JM
    Nitric Oxide; 2012 Oct; 27(3):150-60. PubMed ID: 22705913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.
    Mihu MR; Cabral V; Pattabhi R; Tar MT; Davies KP; Friedman AJ; Martinez LR; Nosanchuk JD
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds.
    Hlaing SP; Kim J; Lee J; Hasan N; Cao J; Naeem M; Lee EH; Shin JH; Jung Y; Lee BL; Jhun BH; Yoo JW
    Eur J Pharm Biopharm; 2018 Nov; 132():94-102. PubMed ID: 30223029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection.
    Martinez LR; Han G; Chacko M; Mihu MR; Jacobson M; Gialanella P; Friedman AJ; Nosanchuk JD; Friedman JM
    J Invest Dermatol; 2009 Oct; 129(10):2463-9. PubMed ID: 19387479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles and current applications of S-nitrosoglutathione in anti-infective biomaterials.
    Qian H; Ye Z; Pi L; Ao J
    Mater Today Bio; 2022 Dec; 16():100419. PubMed ID: 36105674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds.
    Chouake J; Schairer D; Kutner A; Sanchez DA; Makdisi J; Blecher-Paz K; Nacharaju P; Tuckman-Vernon C; Gialanella P; Friedman JM; Nosanchuk JD; Friedman AJ
    J Drugs Dermatol; 2012 Dec; 11(12):1471-7. PubMed ID: 23377518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection.
    Han G; Martinez LR; Mihu MR; Friedman AJ; Friedman JM; Nosanchuk JD
    PLoS One; 2009 Nov; 4(11):e7804. PubMed ID: 19915659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferriheme catalyzes nitric oxide reaction with glutathione to form S-nitrosoglutathione: A novel mechanism for formation of S-nitrosothiols.
    Nagababu E
    Free Radic Biol Med; 2016 Dec; 101():296-304. PubMed ID: 27693379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional Antimicrobial Polypeptide-Selenium Nanoparticles Combat Drug-Resistant Bacteria.
    Huang T; Holden JA; Reynolds EC; Heath DE; O'Brien-Simpson NM; O'Connor AJ
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55696-55709. PubMed ID: 33249831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation.
    Wu W; Gaucher C; Diab R; Fries I; Xiao YL; Hu XM; Maincent P; Sapin-Minet A
    Eur J Pharm Biopharm; 2015 Jan; 89():1-8. PubMed ID: 25448077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric Oxide-Releasing
    Lee J; Kwak D; Kim H; Kim J; Hlaing SP; Hasan N; Cao J; Yoo JW
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32630779
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and characterization of biogenic selenium nanoparticles with antimicrobial properties made by Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, and Pseudomonas aeruginosa.
    Medina Cruz D; Mi G; Webster TJ
    J Biomed Mater Res A; 2018 May; 106(5):1400-1412. PubMed ID: 29356322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-Nitrosoglutathione-Based Nitric Oxide-Releasing Nanofibers Exhibit Dual Antimicrobial and Antithrombotic Activity for Biomedical Applications.
    Douglass M; Hopkins S; Pandey R; Singha P; Norman M; Handa H
    Macromol Biosci; 2021 Jan; 21(1):e2000248. PubMed ID: 33021079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide releasing two-part creams containing S-nitrosoglutathione and zinc oxide for potential topical antimicrobial applications.
    Doverspike JC; Zhou Y; Wu J; Tan X; Xi C; Meyerhoff ME
    Nitric Oxide; 2019 Sep; 90():1-9. PubMed ID: 31170453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis.
    Cardozo VF; Lancheros CA; Narciso AM; Valereto EC; Kobayashi RK; Seabra AB; Nakazato G
    Int J Pharm; 2014 Oct; 473(1-2):20-9. PubMed ID: 24979535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatible biodegradable polymeric antibacterial nanoparticles for enhancing the effects of a third-generation cephalosporin against resistant bacteria.
    Mushtaq S; Khan JA; Rabbani F; Latif U; Arfan M; Yameen MA
    J Med Microbiol; 2017 Mar; 66(3):318-327. PubMed ID: 28150580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses.
    Schairer D; Martinez LR; Blecher K; Chouake J; Nacharaju P; Gialanella P; Friedman JM; Nosanchuk JD; Friedman A
    Virulence; 2012; 3(1):62-7. PubMed ID: 22286699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.